Trial Profile
Efficacy of lenalidomide maintenance therapy in patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 26 Oct 2016 New trial record
- 28 Sep 2016 Results published in the Cancer